Evidence map›Paper›PMID 34512185›Full record

ArticleJournal of public affairs2021

Critical prerequisites for Covid-19 vaccine acceleration: A developing economy perspective.

Robert E Hinson, Wolfgang Hein, Louis N Tettey, Betty A Nartey, Anne Harant, Nicole S Struck, Julius N Fobil

Open access · bronzeAbstract read
In one paragraph

Article in Journal of public affairs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Robert E HinsonUniversity of Ghana Business School Accra Ghana.ORCID https://orcid.org/0000-0003-3302-4888
Wolfgang HeinGerman Institute for Global and Area Studies (GIGA) University of Hamburg Hamburg Germany.
Louis N TetteyUniversity of Ghana Business School Accra Ghana.ORCID https://orcid.org/0000-0002-0664-7003
Betty A NarteySchool of Public Health University of Ghana Accra Ghana.ORCID https://orcid.org/0000-0002-7308-4132
Anne HarantGerman Institute for Global and Area Studies (GIGA) University of Hamburg Hamburg Germany.
Nicole S StruckDepartment of Infectious Disease Epidemiology Bernhard Nocht Institute for Tropical Medicine Hamburg Germany.
Julius N FobilSchool of Public Health University of Ghana Accra Ghana.
University of Ghana · GHUniversität Hamburg · DEGerman Center for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to explore the critical prerequisites for accelerating the distribution of the COVID-19 vaccine in developing countries by using Ghana as a case study. A qualitative study method and content analysis approach was used. In-depth interviews were conducted with health experts from the Ghana Health Service, World Health Organization (WHO), AstraZeneca, Novartis, and Medtronic Inc. in Ghana. Our analysis of data revealed that new structures, committees, advisory bodies and lines of communication in government evolved during this pandemic and are underlying the current strategy development and decision-making on COVID-19 vaccines. The interviews gave insights into six major factors that will aid COVID-19 vaccine acceleration in Ghana. These factors are: (1) Access to vaccines through delivery, (2) national manufacturing of vaccines, (3) choosing the best vaccine candidates, (4) financial resources, (5) transparency, and (6) vaccine roll-out and administration. These results could guide policymakers and other relevant stakeholders in prioritizing activities that will aid COVID-19 vaccine acceleration in Ghana and other lower-middle-income countries, tailored to their specific context. As a recommendation, the Ghanaian government should embrace a multisectoral synergy approach to fight the disease. The study also provides insights into how vaccine adoption can be accelerated in the case of future pandemics.

Indexed as

COVAXCovid‐19educationGhanavaccine

Identifiers

PMID34512185
PMCPMC8420375
OpenAlexW3184213100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.